Incyte
INCY
#979
Rank
$24.38 B
Marketcap
$119.65
Share price
1.39%
Change (1 day)
12.90%
Change (1 year)

Incyte (INCY) - Total debt

Total debt on the balance sheet as of September 2026 : $37.41 Million USD

According to Incyte's latest financial reports the company's total debt is $37.41 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Incyte - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$40.41 M-7.19%
2024-12-31$43.54 M13.73%
2023-12-31$38.28 M-7.65%
2022-12-31$41.45 M-7.51%
2021-12-31$44.82 M-5.7%
2020-12-31$47.53 M-21.08%
2019-12-31$60.22 M66.69%
2018-12-31$36.13 M50.54%
2017-12-31$24 M-96.32%
2016-12-31$0.65 B5.1%
2015-12-31$0.61 B-8.19%
2014-12-31$0.67 B2.06%
2013-12-31$0.66 B99.82%
2012-12-31$0.33 B4.72%
2011-12-31$0.31 B7.74%
2010-12-31$0.29 B-33.78%
2009-12-31$0.44 B11.86%
2008-12-31$0.39 B2.49%
2007-12-31$0.38 B4.16%
2006-12-31$0.37 B8.55%
2005-12-31$0.34 B-9.74%
2004-12-31$0.37 B125.74%
2003-12-31$0.16 B-2.47%
2002-12-31$0.17 B-4.02%
2001-12-31$0.17 B-4.56%
2000-12-31$0.18 B93807%
1999-12-31$0.2 M-75%
1998-12-31$0.8 M
1996-12-31$0.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
$48.31 B 129,029.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$63.19 B 168,813.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$49.50 B 132,218.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$57.30 B 153,070.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$1.13 B 2,924.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.12 B 226.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
$48.89 M 30.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$38.68 M 3.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.25 B 584.78%๐Ÿ‡บ๐Ÿ‡ธ USA